Ehrfeld Mikrotechnik BTS (EMB), a subsidiary of Bayer Technology Services and a leading supplier of microreaction technology products, has acquired a worldwide licence from Alfa Laval to market and manufacture ART reactor technology. With these millistructured plate reactors, which are used in laboratory, pilot and production plants, EMB is now the leading supplier of metal micro- and millistructured reactors and apparatus.
Micro- and millireactor technology offers substantial advantages over batch and other reactors, particularly in the pharmaceutical industry. In addition to numerous other aspects, the outstanding heat transfer and simple scale-up are said to provide advantage for process intensification with respect to yield, costs and safety.
'Ehrfeld Mikrotechnik BTS is a highly-qualified and experienced partner that will hold the exclusive rights to our ART reactor technology in the future,' said Alex Syed, Vice President and Head of Alfa Laval´s Corporate Development.
'The ART reactor technology from Alfa Laval enables us to ideally round out our portfolio of innovative, robust plate reactors for production use,' said EMB Managing Director Dr Joachim Heck. 'We are pleased that we were able to enter into a license agreement with such a prominent company, which has for decades been among the best in the world for heat transfer, mixing, separation and continuous fluid handling technologies.'
